Drug makers' 'Doughnut Hole' Deal To Shave Sales Less Than 1%

BRIEF: Drug makers' 'Doughnut Hole' Deal To Shave Sales less than 1% [The Indianapolis Star]


From Indianapolis Star (IN) (October 1, 2010)


Oct. 01--Drug makers led by Pfizer Inc., AstraZeneca and Bristol-Myers Squibb Co. may provide more than $2 billion in drug discounts to senior citizens next year under a deal pharmaceutical companies made with the White House, according to data compiled by Bloomberg.

Pfizer, the world’s largest drug company, will cede less than half of 1 percent of its $50 billion in annual revenue under the arrangement. The deal provides Medicare beneficiaries who fall into a coverage gap known as the "doughnut hole" 50 percent off brand-name medications. Worldwide sales by brand- name drug makers in 2008 totaled $288 billion, according to data from the drug industry’s trade association.

"This was a good deal for pharma," said Les Funtleyder, a health care analyst with New York-based Miller Tabak & Co. The data "disputes the narrative that health care reform is bad for pharmaceuticals, and as more data emerges I think you’re going to see that narrative play out across the health industry," he said in a telephone interview with Bloomberg.

The drug industry struck the deal with Democrats, who incorporated it into the health care overhaul President Barack Obama signed in March.

To see more of The Indianapolis Star or to subscribe to the newspaper, go to http://www.indystar.com/.

Copyright (c) 2010, The Indianapolis Star

Distributed by McClatchy-Tribune Information Services.

For more information about the content services offered by McClatchy-Tribune Information Services (MCT), visit www.mctinfoservices.com, e-mail services@mctinfoservices.com, or call 866-280-5210 (outside the United States, call +1 312-222-4544)

 

Posted: October 2010


View comments

Hide
(web5)